Advertisement
Screener

MiMedx Group, Inc. (MDXG) Proceeds from Lines of Credit

MiMedx Group, Inc. Proceeds from Lines of Credit

MiMedx Group, Inc. (MDXG) reported Proceeds from Lines of Credit of $0 for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-13.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromLinesOfCredit · last filed 2012-11-13

  • MiMedx Group, Inc. proceeds from lines of credit for the quarter ending 2012-09-30 was $0.00.
  • MiMedx Group, Inc. proceeds from lines of credit for the quarter ending 2012-06-30 was $0.00, a 100.00% decline year-over-year.
  • MiMedx Group, Inc. proceeds from lines of credit for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
  • MiMedx Group, Inc. proceeds from lines of credit for the quarter ending 2011-12-31 was $0.00.
  • MiMedx Group, Inc. proceeds from lines of credit for fiscal 2011 was $1.30M.
  • MiMedx Group, Inc. proceeds from lines of credit for fiscal 2010 was $0.00.
Period endProceeds from Lines of Credit 3 monthProceeds from Lines of Credit 6 monthProceeds from Lines of Credit 9 monthProceeds from Lines of Credit 12 month
2012-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13
$0.00
derived: sum of 2 quarters · filed 2012-11-13
$0.00
10-Q · filed 2012-11-13
$0.00
derived: sum of 4 quarters · filed 2012-11-13
2012-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14
$0.00
10-Q · filed 2012-08-14
$0.00
derived: sum of 3 quarters · filed 2012-08-14
$0.00
derived: sum of 4 quarters · filed 2012-11-13
2012-03-31$0.00
10-Q · filed 2012-05-14
$0.00
derived: sum of 2 quarters · filed 2012-05-14
$0.00
derived: sum of 3 quarters · filed 2012-11-13
$500.00K
derived: sum of 4 quarters · filed 2012-11-13
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29
$0.00
derived: sum of 2 quarters · filed 2012-11-13
$500.00K
derived: sum of 3 quarters · filed 2012-11-13
$1.30M
10-K · filed 2012-03-29
2011-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13
$500.00K
derived: sum of 2 quarters · filed 2012-11-13
$1.30M
10-Q · filed 2012-11-13
$1.30M
derived: sum of 4 quarters · filed 2012-11-13
2011-06-30$500.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14
$1.30M
10-Q · filed 2012-08-14
$1.30M
derived: sum of 3 quarters · filed 2012-08-14
$1.30M
derived: sum of 4 quarters · filed 2012-08-14
2011-03-31$800.00K
10-Q · filed 2012-05-14
$800.00K
derived: sum of 2 quarters · filed 2012-05-14
$800.00K
derived: sum of 3 quarters · filed 2012-05-14
2010-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29
$0.00
derived: sum of 2 quarters · filed 2012-03-29
$0.00
10-K · filed 2012-03-29
2010-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$0.00
10-Q · filed 2011-11-14
2010-06-30$0.00
10-Q · filed 2011-08-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
SpyGlass Pharma, Inc. (SGP)United States$0.925B